There is no current cure for<unk> , only treatments to help alleviate the current symptoms and to help prevent the development of further symptoms. If a source of bleeding can be identified (sources are frequently not found), then surgical correction of the bleeding source can be performed; this has proved to be effective in halting the development of further symptoms in some cases and has no effect on symptoms that have already presented. Patients with<unk>  are often treated with deferiprone (brand name is Ferriprox), a lipid-soluble iron chelator, as this medication has been demonstrated to chelate iron in the central nervous system. Deferiprone use is associated with severe neutropenia, but this risk and associated complications are usually minimised by administering a weekly blood test that measures absolute neutrophil count. Alleviation of the most common symptom, hearing loss, has been varyingly successful through the use of cochlear implants. Most people do not notice a large improvement after successful implantation, which is most likely due to damage to the vestibulocochlear nerve (cranial nerve VIII) and not the cochlea itself. Some people fare far better, with a return to near-normal hearing, but there is little ability to detect how well a person will respond to this treatment at this time.
Superficial siderosis
Geographic atrophy
Neurofibrillary tangle
Polymicrogyria
Posterior cortical atrophy
Amyloid plaques
Hippocampal sclerosis
Hemosiderin hyperpigmentation